Arthur J. Van De Vyver

Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab

Nicolas Frances, Marina Bacac, Katharine Bray‐French et al. · Journal of Pharmaceutical Sciences · 2021 · 32 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining <i>In Vitro</i> Experiments with Systems Modeling

Arthur J. Van De Vyver, Tina Weinzierl, Miro J. Eigenmann et al. · Molecular Cancer Therapeutics · 2020 · 25 citations · Full text

Life Sciences, Immunology, Oncology +17

Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration

Arthur J. Van De Vyver, Antje‐Christine Walz, Mariette Heins et al. · Frontiers in Pharmacology · 2022 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

A Novel Approach for Quantifying the Pharmacological Activity of T-Cell Engagers Utilizing In Vitro Time Course Experiments and Streamlined Data Analysis

Arthur J. Van De Vyver, Miro J. Eigenmann, Meric Ovacik et al. · The AAPS Journal · 2021 · 10 citations · Full text

Medicine, Immunology, Pharmacology +14